PUBLICACIÓN

CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment

ACCEDER A LA PUBLICACIÓN: Scopus Orcid

Almoguera B. et al.

2013 Pharmacogenetics and Genomics

Genetics (Q2), Genetics (clinical) (Q2), Molecular Biology (Q2), Molecular Medicine (Q2)

JCR: 3.45

SJR: 1.317


CITAS

31

DOI

10.1097/fpc.0b013e3283659a94

EID

2-s2.0-84886597555

ISSN

1744-6872

EISSN

1744-6880

BIBTEX

@article{Dorado2013,title = {CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment},journal = {Pharmacogenetics and Genomics},year = {2013},volume = {23},number = {11},pages = {627-630},author = {Almoguera, B. and Riveiro-Alvarez, R. and Lopez-Castroman, J. and Dorado, P. and Vaquero-Lorenzo, C. and Fernandez-Piqueras, J. and Llerena, A. and Abad-Santos, F. and Baca-Garc{\'i}a, E. and Dal-R{\'e}, R. and Ayuso, C.}}


AUTORES DE LA UEX